BioCentury | Sep 10, 2020
Emerging Company Profile

Generate: applying machine learning to protein design

...serves as president of Generate and Afeyan is the new company’s chairman.Generate’s board also includes California Institute of Technology’s...
BioCentury | May 19, 2020
Finance

May 19 Quick Takes: Cowen closes $493M fund; plus Guangzhou BeBetter, Fountain Therapeutics, Amplyx, ChromaCode, Applied Molecular

...Ventures, New Enterprise Associates, Domain Associates, Windham Ventures, Okapi Ventures, Moore Venture Partners and the California Institute of Technology...
BioCentury | May 9, 2020
Product Development

With Nuevolution’s DNA-encoded libraries, Amgen takes on targeted degradation and beyond

...one in a billion molecule, but that’s where DEL comes in.” Formerly a professor at California Institute of Technology...
BioCentury | Jul 25, 2019
Emerging Company Profile

Axial: targeting gut microbe metabolites for CNS disorders

...partner, to co-lead the company’s series A round. Mazmanian, a professor of microbiology at the California Institute of Technology...
...cancer Clinical status: Phase I Founded: 2016 by Sarkis Mazmanian and David Donabedian University collaborators: California Institute of Technology...
...Donabedian Patents: At least 60 issued Companies and Institutions Mentioned Axial Biotherapeutics Inc., Waltham, Mass. California Institute of Technology...
BioCentury | Jun 3, 2019
Preclinical News

June 3 Preclinical Quick Takes: 'CRISPR baby' gene mutation increases mortality; Axial's microbiome for autism

...behavioral symptoms of autism Axial Biotherapeutics Inc. (Boston, Mass.) co-founder Sarkis Mazmanian and colleagues at California Institute of Technology...
...model of autism (see "Seventure Leads Axial's $25M Series B" ). Mary Romeo, Staff Writer Axial Biotherapeutics Inc. California Institute of Technology Seventure...
BioCentury | Mar 1, 2019
Financial News

Seventure leads Axial's $25M series B

...finding adequate chemical interventions on these mechanisms with remarkable efficacy.” Mazmanian is a professor at California Institute of Technology...
BioCentury | Feb 27, 2019
Financial News

Seventure leads Axial's $25M series B

...finding adequate chemical interventions on these mechanisms with remarkable efficacy.” Mazmanian is a professor at California Institute of Technology...
BioCentury | Dec 1, 2018
Politics, Policy & Law

China’s germline growing pain

...failure of self-regulation by the scientific community because of this lack of transparency.” David Baltimore, California Institute of Technology...
...lack of transparency,” said David Baltimore at the summit. Baltimore is professor emeritus at the California Institute of Technology...
...China BGI Genomics Co. Ltd. (SZSE:300676), Shenzhen, China Bill & Melinda Gates Foundation, Seattle, Wash. California Institute of Technology...
BioCentury | Oct 31, 2018
Translation in Brief

Programming cell circuits

...in DNA-encoded therapies. In a September paper published in Science , a team from the California Institute of Technology...
...Strand holds IP rights to the viral protease-based approach to regulate mRNA translation. Chris Lieu, Staff Writer California Institute of Technology Howard...
BioCentury | Oct 3, 2018
Politics & Policy

Phage display founders win Nobel for chemistry

...Biology (Cambridge, U.K.). The other half went to Frances Arnold, who is a professor at California Institute of Technology...
Items per page:
1 - 10 of 159
BioCentury | Sep 10, 2020
Emerging Company Profile

Generate: applying machine learning to protein design

...serves as president of Generate and Afeyan is the new company’s chairman.Generate’s board also includes California Institute of Technology’s...
BioCentury | May 19, 2020
Finance

May 19 Quick Takes: Cowen closes $493M fund; plus Guangzhou BeBetter, Fountain Therapeutics, Amplyx, ChromaCode, Applied Molecular

...Ventures, New Enterprise Associates, Domain Associates, Windham Ventures, Okapi Ventures, Moore Venture Partners and the California Institute of Technology...
BioCentury | May 9, 2020
Product Development

With Nuevolution’s DNA-encoded libraries, Amgen takes on targeted degradation and beyond

...one in a billion molecule, but that’s where DEL comes in.” Formerly a professor at California Institute of Technology...
BioCentury | Jul 25, 2019
Emerging Company Profile

Axial: targeting gut microbe metabolites for CNS disorders

...partner, to co-lead the company’s series A round. Mazmanian, a professor of microbiology at the California Institute of Technology...
...cancer Clinical status: Phase I Founded: 2016 by Sarkis Mazmanian and David Donabedian University collaborators: California Institute of Technology...
...Donabedian Patents: At least 60 issued Companies and Institutions Mentioned Axial Biotherapeutics Inc., Waltham, Mass. California Institute of Technology...
BioCentury | Jun 3, 2019
Preclinical News

June 3 Preclinical Quick Takes: 'CRISPR baby' gene mutation increases mortality; Axial's microbiome for autism

...behavioral symptoms of autism Axial Biotherapeutics Inc. (Boston, Mass.) co-founder Sarkis Mazmanian and colleagues at California Institute of Technology...
...model of autism (see "Seventure Leads Axial's $25M Series B" ). Mary Romeo, Staff Writer Axial Biotherapeutics Inc. California Institute of Technology Seventure...
BioCentury | Mar 1, 2019
Financial News

Seventure leads Axial's $25M series B

...finding adequate chemical interventions on these mechanisms with remarkable efficacy.” Mazmanian is a professor at California Institute of Technology...
BioCentury | Feb 27, 2019
Financial News

Seventure leads Axial's $25M series B

...finding adequate chemical interventions on these mechanisms with remarkable efficacy.” Mazmanian is a professor at California Institute of Technology...
BioCentury | Dec 1, 2018
Politics, Policy & Law

China’s germline growing pain

...failure of self-regulation by the scientific community because of this lack of transparency.” David Baltimore, California Institute of Technology...
...lack of transparency,” said David Baltimore at the summit. Baltimore is professor emeritus at the California Institute of Technology...
...China BGI Genomics Co. Ltd. (SZSE:300676), Shenzhen, China Bill & Melinda Gates Foundation, Seattle, Wash. California Institute of Technology...
BioCentury | Oct 31, 2018
Translation in Brief

Programming cell circuits

...in DNA-encoded therapies. In a September paper published in Science , a team from the California Institute of Technology...
...Strand holds IP rights to the viral protease-based approach to regulate mRNA translation. Chris Lieu, Staff Writer California Institute of Technology Howard...
BioCentury | Oct 3, 2018
Politics & Policy

Phage display founders win Nobel for chemistry

...Biology (Cambridge, U.K.). The other half went to Frances Arnold, who is a professor at California Institute of Technology...
Items per page:
1 - 10 of 159